Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Müller

Showing results (281-290 of 392) with videos related to

Pageof 40
Sort By:
ACS Infectious Diseases|November 20, 2024
In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative PathogensAndreas M Kany, Franziska Fries, Carsten E Seyfert, et al.
Breast Cancer Research and Treatment|November 28, 2017
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancerS L Villegas, S Darb-Esfahani, G von Minckwitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patientsV Möbus, G von Minckwitz, C Jackisch, et al.
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study NetworkP A Fasching, S Y Brucker, T N Fehm, et al.
ESMO Open|November 10, 2022
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)M Schmidt, K Lübbe, T Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2018
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network RegistryI Witzel, E Laakmann, R Weide, et al.
ESMO Open|June 11, 2026
First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA studyM Schmidt, M Thill, J Rey, et al.
Nature Plants|June 2, 2016
Global conservation priorities for crop wild relativesNora P Castañeda-Álvarez, Colin K Khoury, Harold A Achicanoy, et al.
Gut Microbes|November 22, 2023
Detecting host responses to microbial stimulation using primary epithelial organoidsJette Bornholdt, Christina V Müller, Maria Juul Nielsen, et al.
Breast (Edinburgh, Scotland)|July 22, 2017
Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A studyElisabeth Trapp, J Steidl, B Rack, et al.
Pageof 40

Showing results (281-290 of 392) with videos related to

Sort By:
Pageof 40
ACS Infectious Diseases|November 20, 2024
In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative PathogensAndreas M Kany, Franziska Fries, Carsten E Seyfert, et al.
Breast Cancer Research and Treatment|November 28, 2017
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancerS L Villegas, S Darb-Esfahani, G von Minckwitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patientsV Möbus, G von Minckwitz, C Jackisch, et al.
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study NetworkP A Fasching, S Y Brucker, T N Fehm, et al.
ESMO Open|November 10, 2022
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)M Schmidt, K Lübbe, T Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2018
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network RegistryI Witzel, E Laakmann, R Weide, et al.
ESMO Open|June 11, 2026
First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA studyM Schmidt, M Thill, J Rey, et al.
Nature Plants|June 2, 2016
Global conservation priorities for crop wild relativesNora P Castañeda-Álvarez, Colin K Khoury, Harold A Achicanoy, et al.
Gut Microbes|November 22, 2023
Detecting host responses to microbial stimulation using primary epithelial organoidsJette Bornholdt, Christina V Müller, Maria Juul Nielsen, et al.
Breast (Edinburgh, Scotland)|July 22, 2017
Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A studyElisabeth Trapp, J Steidl, B Rack, et al.
Pageof 40